期刊文献+

融合蛋白IFN-IgGFc在乳酸乳杆菌中的表达及其生物学活性研究 被引量:1

Expression and Bioactivities Study on IFN-IgG Fc Fusion Protein in Lactobacillus casei
在线阅读 下载PDF
导出
摘要 用乳酸菌表达有药用价值的生物学活性多肽,是当前国际上的研究热点之一,对开发新的功能性食品具有广阔的前景。本文应用PCR方法将人干扰素IFN-α-2b基因与IgGFc基因连接,并引入一段柔性连接肽,构建了融合蛋白基因IFN-IgGFc,将融合蛋白基因克隆到原核表达载体pSC111AE中,转化乳酸乳杆菌ATCC393进行诱导表达及鉴定,并研究了融合蛋白的生物学活性。结果表明,通过Western-Blot方法在表达上清液检测出干扰素融合蛋白,ELISA测定表明两段多肽能够保持各自的构象,基因工程乳酸菌表达的上清液可以诱导WISH细胞产生明显的抗VSV病毒的活性,其活性为1.71×103IU/ml。本文首次构建并在大肠杆菌和乳酸菌表达了IFN-IgGFc融合蛋白,获得了能产生人干扰素的乳酸菌株,为基因工程乳酸菌及相关药物的开发研究奠定了基础。 Expressing bioactive polypeptide by using gene modified LAB is one of the most popular researches in the world. It has a good potential to develop new functional food. IFN-α-2b and IgG Fc gene were PCR amplified and linked by a flexible hinge to code for a fusion protein IFN-IgG Fc. The fusion gene was cloned to pSC111 AE vector and electro-transformed into Lactobacillus casei ATCC393. We studied the biological activities of the expression product in vitro. The results showed that we can detect the fusion protein in the supematant by Western-Blot. The results of ELISA showed that there is no effect on conformation and biological activity between the two proteins. We found that supematant of recombinant LAB can introduce the antiviral activity in WISH cells and the anti-viral activity of the product is about 1.71×10^3IU/ml. The study laid a foundation for further use of modified LAB in the domains of food technology and drug development.
出处 《食品科学》 EI CAS CSCD 北大核心 2007年第1期205-208,共4页 Food Science
关键词 乳酸菌 干扰素 融合蛋白 抗病毒 lactic acid bacteria interferon fusion protein antivirus
  • 相关文献

参考文献11

  • 1REID G J,SEBULSKY M T,et al.Potential uses of probiotics in clinical practice[J].Clin Microbiol Rev,2003,16 (4):6582-6721.
  • 2BOLOTIN A B,WINCKER P,MAUGER S,et al.The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp.lactis IL1403[J].Genome Res,2001,(11):731-753.
  • 3GASSON M J.In vivo genetic systems in lactic acid bacteria[J].FEMS Microbiol Rev,1990,87:43-60.
  • 4VOS W M.Safe and sustainable systems for food-grade fermentation by genetically modified lactic acid bacteria[J].Int Dairy,1999(9):3-10.
  • 5VOS W M.Gene expression systems for lactic acid bacteria[J].Current Opinion in Microbiology,1999(2):289-295.
  • 6MARTIN M C,ALONSO J C,SUAREZ J E,et al.Generation of foodgrade recombinant lactic acid bacterium strains by site-specific recombination[J].Appl Environ Microbiol,2000,66:2599-2604.
  • 7LEENHOUTS K,BOLHUIS A,VENEMA G,et al.Construction of a food-grade multiple-copy integration system for Lactococcus lactis[J].Appl Microbiol Biotechnol,1998,49:417-423.
  • 8MACCORMICK C A,GRIFFIN H G,GASSON M J.Construction of a food grade host/vector system for Lactococcus lactis based on the lactose operon[J].FEMS Microbiol Lett,1995,127:105-109.
  • 9吕晓英,张朝武,裴晓方,余倩,宋悦红.作为宿主系统的几株乳酸菌的表型特征[J].中国微生态学杂志,2001,13(5):265-266. 被引量:3
  • 10CORSSMIT E P M,METZ J De,SAUERWEIN H P,et al.Biologic respinses to IFN-2 α administration in humans[J].J Interferon and Cytokine Res,2000,20:1039-1047.

二级参考文献7

  • 1[1]Mckay LL. Functional properties of plasmids in lactic streptococci[J]. Antonie Van Leeuwenhoek J Microbiol, 1983, 49 (3): 259-274.
  • 2[2]Mckay LL, Baldwin KA. Applications for biotechnology: present and future improvements in lactic acid bacteria[J]. FCMS Microbiol Rev,1990:87(1-2) :3-4.
  • 3[3]Kliin N,Weerkamp AH,de Vos MWM. Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract [J]. J Appl Bacteriol,1989,66(5) :365-378.
  • 4[4]Fuller R. Probiotics in man and animals[J]. J Appl Bacteriol,1989,66 (5) : 365-378.
  • 5[5]Watkins BA ,Miller BF. Colonization of Lactobacillus acidophilus in gnotobiotic chicks[J]. Poult Sci,1983,62(11):2152-2157.
  • 6[6]Wells JM,Wilson PW ,Le Page RWF. Improved cloning vectors and transformation procedure for Lactococcus lactis[J]. J Appl Bacteriol, 1993,74(6): 629-636.
  • 7杨洁彬,乳酸菌.生物学基础及应用,1996年,139,177,187页

共引文献36

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部